Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | TNNI1 |
| Upstream (Parents) |
|---|
| (<<) MYL1 → TNNI1 |
| (<<) MYH7///MYH6 → TNNI1 |
| (<<) TNNI2 → TNNI1 |
| Downstream (Children) |
|---|
| TNNI1 → ANKRD2 (>>) |
| TNNI1 → CASQ1 (>>) |
| TNNI1 → TPM3 (>>) |
| TNNI1 → TPM1 (>>) |
| TNNI1 → ANKRD1 (>>) |
| TNNI1 → AMPD1 (>>) |
| TNNI1 → COX6A2 (>>) |
| TNNI1 → TCAP (>>) |
| TNNI1 → NEB (>>) |
| TNNI1 → TNNT3 (>>) |
| TNNI1 → ATP2A1 (>>) |
| TNNI1 → CASQ2 (>>) |
| TNNI1 → HRC (>>) |
| TNNI1 → MYF6 (>>) |
| TNNI1 → MYOZ2 (>>) |
| TNNI1 → MYH1 (>>) |
| TNNI1 → MYH7///MYH6 (>>) |
| TNNI1 → MYOT (>>) |
| TNNI1 → CSRP3 (>>) |
| TNNI1 → TNNC2 (>>) |
| TNNI1 → MYBPC2 (>>) |
| TNNI1 → MB (>>) |
| TNNI1 → FAM48A///DES (>>) |
| TNNI1 → ACTN2 (>>) |
| TNNI1 → TNNI2 (>>) |
| TNNI1 → PGAM2 (>>) |
| TNNI1 → MYOZ1 (>>) |
| TNNI1 → ACTC1 (>>) |
| TNNI1 → CACNA1S (>>) |
| TNNI1 → RYR1 (>>) |
